← FDA DRUG APPROVALS

FDA ANDA · ANDA083261

SODIUM PENTOBARBITAL

Sponsor: WYETH AYERST

APPLICATION
ANDA083261
TYPE
ANDA
ORIGINAL APPROVAL
1973-12-19
LATEST ACTION
1993-07-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

SODIUM PENTOBARBITALDiscontinued
PENTOBARBITAL SODIUM 50MG/ML · INJECTABLE · INJECTION

Approval history

1993-07-30Manufacturing (CMC) · Supplement 11AP
1993-07-30Manufacturing (CMC) · Supplement 10AP
1989-11-15Labeling · Supplement 9AP
1987-04-28Manufacturing (CMC) · Supplement 7AP
1983-08-12Manufacturing (CMC) · Supplement 5AP
1983-08-12Manufacturing (CMC) · Supplement 4AP
1973-12-19OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →